Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025Indus journal of bioscience research.Open Access

Prevalence of Rifampicin Resistance in Pediatric Patients with Mycobacterium Tuberculosis Using Gene Expert in Gulab Devi Hospital

View Full Paper
Ask AI
Bookmark
Share

Authors

ATAyesha TariqMNMuhammad Naeem

Discussion

Loading...

Member takes

Overview

Cross-sectional study assessed rifampicin resistance in pediatric tuberculosis cases, indicating prevalence at 8% in the region.

Key Points

  • The study found a prevalence of rifampicin resistance at 8% among pediatric patients with tuberculosis.
  • Using the Xpert MTB/RIF assay, samples were analyzed to detect rifampicin resistance in newly diagnosed cases.
  • Conducted over six months at Gulab Devi Hospital, the study involved 150 pediatric patients diagnosed with tuberculosis.
  • The findings suggest a relatively low prevalence of rifampicin resistance in this population, highlighting management opportunities.

Cite This Study

Tariq et al. (2025) studied this question.

synapsesocial.com/papers/68af2d76cf1dd9ea359e5545https://doi.org/10.70749/ijbr.v3i7.2004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1GeneXpert MTB/RIF in diagnosis of tuberculous meningitis (TBM) in paediatric patients at a tertiary care children’s hospital in Pakistan over a period of 4 years2025 · 1 citations
  2. 2Prevalence of rifampicin resistance in pulmonary tuberculosis: A laboratory-based study2025
  3. 3Early Diagnostic Utility of Genexpert for the Detection of <i>Mycobacterium tuberculosis</i>2025
  4. 4Positivity Proportion of Xpert MTB/RIF in Suspected Pediatric Pulmonary Tuberculosis Patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia2025
  5. 5Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.2025 · 1 citations